Meet Our Team
Our Expertise
Cyanos Group is a leading M&A Advisory group specialized in lifesciences and healthcare. With a dedicated team boasting over two decades of industry experience, we provide comprehensive services to pharma and biotech companies, AI service firms, CROs, CDMOs, and clinical laboratories, globally. Our focus lies in delivering A-Z services for both sell-side and buy-side clients, ensuring seamless and value-driven M&A transactions.
Practice Areas
Our Edge
1
Healthcare Industry Expertise
25 years industry expertise of all aspects of laboratory service including scientific, operational, commercialization, and M&A. Saving time and money providing an intelligence-based transaction.
2
Tailored Approaches
We implement tailored approaches that align with the specific objectives and requirements of each client, ensuring the delivery of customized M&A solutions for sustainable growth and success.
3
Client-Centric Focus
Whether you are looking to enhance your operation, reach new geographic zones, improve your bottom line, or simply exist your business we are focused on your needs.
4
Innovative Strategies
We employ innovative strategies to address the complexities of M&A transactions, relying on industry KOL, proprietary and public databases
Our Focus
Strategic Transactions
Operational Integration
We specialize in strategic transactions, enabling our clients to navigate complex M&A deals with confidence and precision. Our operational integration services are designed to streamline processes and maximize synergies for post-merger success.
Due Diligence
Deal Structuring
Our team ensures thorough due diligence, offering meticulous insights to support informed decision-making during M&A transactions. We provide expert both technical evaluation and deal structuring guidance to optimize value and mitigate risks for our clients.
Valuation Services
Integration Strategies
Our valuation services are tailored to uncover and maximize the value of assets and entities involved in M&A deals. We offer comprehensive integration strategies to facilitate a smooth transition and sustainable performance post-transaction.
Synergy Optimization
Risk Management
We specialize in synergy optimization, offering innovative solutions to harness the full potential of combined entities. Our expertise in risk management ensures that M&A transactions are executed with a focus on long-term value creation and growth.
Cyanos Insights
25+
Years of Experience
Extensive Network
Location - The Greater Boston Area
Eitan Akirav, Ph.D.
Dr. Eitan Akirav, is a Founder and Managing Director at Cyanos Group. With over 25 years of experience spanning top-tier academic institutions and leading biotech companies, Eitan Akirav combines deep scientific expertise with strategic business acumen in biotechnology and healthcare. Recognized for driving innovation, fostering cross-functional collaboration, and building resilient teams, he excels at translating complex scientific discoveries into actionable business solutions and high-impact partnerships.
As Director of Business Development at Harvard University, Eitan identified market needs and created commercialization pathways for groundbreaking innovations. In his role as Vice President and Global Lead for Biomarkers at Cerba Research, Eitan drove revenue growth from $3M to $9M within just eight months, even amidst pandemic challenges. He expanded Cerba’s geographic footprint into APAC with a $1.3M clinical trial partnership and directed biomarker programs in cutting-edge therapeutic areas such as immuno-oncology and cell-based therapies.
Eitan holds a Ph.D. in Immunology from Yale School of Medicine, where he also completed postdoctoral fellowships in autoimmunity and diabetes. He earned an M.Sc./M.Phil. in Immunology from Yale, an M.Sc. in Physiology and Endocrinology from the University of Toronto, and a B.Sc. in Biology from Tel Aviv University.
Founder & CEO
